MedTrace Logo

TriVascular Post-Market Registry

NCT01372709 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 501

Last updated 2021-06-04

No results posted yet for this study

Summary

This is a prospective observational post-market study of subjects receiving the Ovation™ or Ovation Prime™ Abdominal Stent Graft System ("Ovation™ or Ovation Prime™ Abdominal Stent Graft System Post-Market Study") in the treatment of abdominal aortic aneurysms (AAA). The Ovation™ or Ovation Prime™ Abdominal Stent Graft System Post-Market study is intended to expand the clinical knowledge base by collecting data on subjects treated with the Ovation™ or Ovation Prime™ Abdominal Stent Graft System in actual clinical practice following commercial approval.

Conditions

  • Abdominal Aortic Aneurysm

Interventions

DEVICE

Ovation™ or Ovation Prime™ Abdominal Stent Graft System

Single occurrence permanent implant of AAA device.

Sponsors & Collaborators

  • TriVascular, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2014-12-12
Completion
2019-06-14

Countries

  • Austria
  • Belgium
  • France
  • Germany
  • Greece
  • Italy
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01372709 on ClinicalTrials.gov